Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL614533 Target Snapshot

C8166 · CELL-LINE · Homo sapiens

1,314Compounds
188Assays
33Approved Drugs
467.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats C8166 as ChEMBL target CHEMBL614533. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
C8166
CELL-LINE · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL614533
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether C8166 still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelC8166
UniProt AccessionN/A

C8166

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as C8166.

Review nameC8166
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

33
Approved
12
Phase III
9
Phase II
5
Phase I
Assay Mix

Activity Type Distribution

IC50275.0
EC50192.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL137838 10.27 EC50 0.054 Preclinical
CHEMBL1554 10.1 IC50 0.08 Approved
CHEMBL336441 9.57 EC50 0.27 Preclinical
CHEMBL338099 9.22 EC50 0.6 Preclinical
CHEMBL329653 9.1 EC50 0.8 Preclinical
CHEMBL212719 9.0 IC50 1.0 Preclinical
CHEMBL344257 8.96 EC50 1.1 Preclinical
CHEMBL293498 8.82 IC50 1.5 Preclinical
CHEMBL105916 8.7 EC50 2.0 Preclinical
CHEMBL114 8.7 EC50 2.0 Approved
Distribution

pChEMBL Value Distribution

47
5.0
22
5.5
50
6.0
23
6.5
43
7.0
30
7.5
19
8.0
10
8.5
5
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

GEMCITABINE
CHEMBL888
Approved 1996
NEVIRAPINE
CHEMBL57
Approved 1996
SAQUINAVIR
CHEMBL114
Approved 1995
DOCETAXEL
CHEMBL3545252
Approved 1995
VINORELBINE
CHEMBL553025
Approved 1994
STAVUDINE
CHEMBL991
Approved 1994
ZALCITABINE
CHEMBL853
Approved 1992
DIDANOSINE
CHEMBL1460
Approved 1991
ZIDOVUDINE
CHEMBL129
Approved 1987
MITOMYCIN
CHEMBL105
Approved 1981
DOXORUBICIN
CHEMBL53463
Approved 1974
VINBLASTINE
CHEMBL159
Approved 1965
DACTINOMYCIN
CHEMBL1554
Approved 1964
METHOTREXATE
CHEMBL34259
Approved 1953
Assay Landscape

Assay Landscape

188
Total Assays
299
Tested Compounds
3
Assay Types
Functional — 114 assays, 299 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 114 299 6.3
ADME — 66 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 66 9 4.7
Toxicity — 8 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 8 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine